IPOs

3 very different biotechs all file for the same IPO goal: A big raise on Nasdaq
Fierce Biotech
Mon, 04/19/21 - 11:08 am
IPOs
NASDAQ
Talaris Therapeutics
Gyroscope Therapeutics
Sagimet Biosciences
Recursion, targeting cancer, rare disease midstage tests, sets terms for $306M IPO
Fierce Biotech
Tue, 04/13/21 - 10:24 am
Recursion Pharmaceuticals
IPOs
artificial intelligence
COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO
Fierce Biotech
Mon, 04/12/21 - 11:25 pm
Valneva
IPOs
COVID-19
Pfizer
Reneo Pharmaceuticals and VectivBio Prepare to Begin Trading on the Nasdaq
BioSpace
Thu, 04/8/21 - 07:51 pm
Reneo Pharmaceuticals
VectivBio
IPOs
NASDAQ
The flotation window stays open, for now
EP Vantage
Thu, 04/8/21 - 10:26 am
IPOs
biotech
flotation
Vaccitech confidentially files for Nasdaq IPO
Endpoints
Wed, 04/7/21 - 07:20 pm
Vaccitech
IPOs
NASDAQ
COVID-19
vaccines
After name change and dropped IPO, IN8bio tries again to boost its cancer pipeline
Fierce Biotech
Mon, 04/5/21 - 10:30 pm
IN8Bio
Incysus Therapeutics
IPOs
Rain Therapeutics headlines newest slate of IPO-bound biotechs with $100M penciled in for lead oncology program
Endpoints
Mon, 04/5/21 - 10:21 pm
IPOs
Rain Therapeutics
Impel NeuroPharma
Anebulo Pharmaceuticals
Achilles Therapeutics’ IPO nabs $175M to bring cell therapies to solid tumors
MedCity News
Thu, 04/1/21 - 10:47 am
Achilles Therapeutics
IPOs
cancer immunotherapy
Three Biopharma Companies Making Their Nasdaq Debut
BioSpace
Mon, 03/29/21 - 10:49 am
IPOs
NASDAQ
Design Therapeutics
Edgewise Therapeutics
Ikena Oncology
Gyroscope bags $148M for AMD gene therapy trials, mulls IPO
Fierce Biotech
Fri, 03/26/21 - 10:53 am
Gyroscope
gene therapy
IPOs
age-related macular degeneration
British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO
Fierce Biotech
Fri, 03/26/21 - 10:44 am
IPOs
Achilles Therapeutics
immuno-oncology
NASDAQ
Recursion will take its AI platform public in latest IPO filing, while rare heart mutation biotech jumps on SPAC train
Endpoints
Tue, 03/23/21 - 10:31 am
Recursion Pharmaceuticals
IPOs
artificial intelligence
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Endpoints
Fri, 03/19/21 - 11:22 am
IPOs
NASDAQ
Instil Bio
Connect Biopharma
Finch Therapeutics
Gain Therapeutics
Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO
MedCity News
Thu, 03/18/21 - 10:52 am
University of Oxford
spinoffs
Vaccitech
vaccines
IPOs
Rubius launches $200m IPO to fund red blood cell therapies
Pharmaforum
Wed, 03/17/21 - 10:40 am
Rubius Therapeutics
IPOs
cell therapy
Prometheus upsizes IPO by 33% ahead of pricing
Endpoints
Thu, 03/11/21 - 11:43 pm
Prometheus Biosciences
IPOs
Are SPACs Better Than Traditional IPOs?
BioSpace
Wed, 03/10/21 - 10:47 pm
IPOs
SPAC
Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering
Endpoints
Mon, 03/8/21 - 09:15 pm
IPOs
Ikena Oncology
Kyn Therapeutics
NASDAQ
Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street
Endpoints
Mon, 03/1/21 - 11:42 pm
IPOs
SPAC
Finch Therapeutics
microbiome
Connect Biopharma
Insil Bio
Transcode Therapeutics

Pages